OSQUIO, created in 2012 (Ireland), from 19 sister brands and 2214 competing brands. OSQUIO is owned by Biomarin Pharmaceutical, listed on the stock exchange of New York OSQUIO is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
Biomarin Pharmaceutical
(OSQUIO)
over 5 years*
USD 77.29